2022 Monkeypox Outbreak:
Global Trends

World Health Organization

Produced on 16 August 2022

logo

1 Overview

This report provides a global overview of the monkeypox epidemiological situation as reported to WHO as of August 15 2022. The report focuses on laboratory confirmed cases1 as defined by the WHO’s working case definition published in the Surveillance, case investigation and contact tracing for monkeypox interim guidance. Note that countries may use their own case definitions separate from those outlined in the above document. This report should be considered in the context of other WHO information products associated with the 2022 monkeypox outbreak, and monkeypox in general:

  • The biweekly Situation Report provides a comprehensive update of the monkeypox situation and response activities across a variety of domains such as epidemiology, clinical management and communications, replacing the previous Disease Outbreak News format;

  • The Emergency Dashboard provides the latest daily data on total cases and deaths of monkeypox, as well as other events and emergencies to which WHO is responding;

  • This global epidemiological report provides in-depth epidemiological information about the monkeypox situation, based primarily on case report forms provided by Member States to WHO under Article 6 of the International Health Regulations (IHR 2005).

Links to these products can be see in more detail at the end of the report.

Since 1 January 2022, cases of monkeypox have been reported to WHO from 92 Member States across all 6 WHO regions. As of August 15 2022 at 17h CEST, a total of 35,275 laboratory confirmed cases and 141 probable cases, including 12 deaths, have been reported to WHO. Since 13 May 2022, a high proportion of these cases have been reported from countries without previously documented monkeypox transmission. This is the first time that cases and sustained chains of transmission have been reported in countries without direct or immediate epidemiological links to areas of West or Central Africa.

With the exception of countries2 areas of West and Central Africa, the ongoing outbreak of monkeypox continues to primarily affect men who have sex with men who have reported recent sex with one or multiple partners. At present there is no signal suggesting sustained transmission beyond these networks.

Confirmation of one case of monkeypox, in a country, is considered an outbreak. The unexpected appearance of monkeypox in several regions in the initial absence of epidemiological links to areas in West and Central Africa, suggests that there may have been undetected transmission for some time.

WHO assesses the global risk as Moderate. Regionally, WHO assesses the risk in the European Region as High and as Moderate in the African Region, Region of the Americas, Eastern Mediterranean Region and the South-East Asia Region. The risk in the Western Pacific Region is assessed as Low-Moderate. The IHR Emergency Committee on the multi-country outbreak of monkeypox held its second meeting on 21 July 2022. Having considered the views of committee members and advisors as well as other factors in line with the International Health Regulations (2005), the WHO Director-General declared this outbreak a public health emergency of international concern and issued temporary recommendations in relation to the outbreak.

 


  1. For the WHO European region, both confirmed and probable cases are included within confirmed case counts and detailed case data.

  2. Throughout this document, any use of the word country should be considered shorthand for a country, area, or territory

  3. All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).


2 Global situation update

The number of weekly1 reported new cases globally has increased by 20% in week 32 (08 Aug - 14 Aug) (n = 7,460 cases) compared to week 31 (01 Aug - 07 Aug) (n = 6,217 cases). The majority of cases reported in the past 4 weeks were notified from the Region of the Americas (54.3%) and the European Region (44.4%).

The 10 most affected countries globally are: United States of America (n = 10,725), Spain (n = 5,719), Germany (n = 3,102), The United Kingdom (n = 3,037), France (n = 2,673), Brazil (n = 2,584), Canada (n = 1,059), Netherlands (n = 1,025), Portugal (n = 770), and Peru (n = 653). Together, these countries account for 88.9% of the cases reported globally.

In the past 7 days, 35 countries reported an increase in the weekly number of cases, with the highest increase reported in United States of America. 19 countries have reported no new cases in the past 21 days.

In the past 7 days, 3 countries reported their first case. countries which reported their first case in the past 7 days are: Republic of Moldova (09 August), Greenland (10 August), Monaco (12 August).

Global data are data collected by public sources. These data are largely aggregated cases that have been reported from open and official country sources. The below epidemic curve shows the aggregated number of cases by week according to the date of case reporting.

2.1 Epidemic curve (cases)

Epidemic curve shown for cases reported up to 14 Aug 2022 to avoid showing incomplete weeks of data.

2.2 Epidemic curve (deaths)

Epidemic curve shown for cases reported up to 14 Aug 2022 to avoid showing incomplete weeks of data.

2.3 Epidemic curve by WHO Region (cases)

Epidemic curve shown for deaths reported up to 14 Aug 2022 to avoid showing incomplete weeks of data. Note different y-axis scales.

2.4 Epidemic curve by WHO Region (deaths)

Epidemic curve shown for deaths reported up to 14 Aug 2022 to avoid showing incomplete weeks of data. Note different y-axis scales.

2.5 Global Map

2.6 Table - Cases and deaths by WHO Region

Total Monkeypox cases, by WHO region
From 1 Jan 2022. Data as of 15 Aug 2022
Total Confirmed Cases Total Probable Cases Total Deaths
European Region 19,218 0 2
Region of the Americas 15,524 141 2
African Region 388 0 7
Western Pacific Region 99 0 0
Eastern Mediterranean Region 33 0 0
South-East Asia Region 13 0 1
Total 35,275 141 12


2.7 Table - Cases and deaths by country

Total Monkeypox cases, by WHO region
From 1 Jan 2022. Data as of 15 Aug 2022
Total Confirmed Cases Total Probable Cases Total Deaths
Region of the Americas
United States of America 10,725 0 0
Brazil 2,584 52 1
Canada 1,059 86 0
Peru 653 0 0
Mexico 147 0 0
Chile 126 1 0
Colombia 84 0 0
Argentina 49 0 0
Puerto Rico 43 0 0
Ecuador 17 1 1
Bolivia (Plurinational State of) 11 0 0
Dominican Republic 5 1 0
Jamaica 4 0 0
Costa Rica 3 0 0
Guatemala 3 0 0
Panama 2 0 0
Uruguay 2 0 0
Bahamas 1 0 0
Barbados 1 0 0
Bermuda 1 0 0
Guadeloupe 1 0 0
Martinique 1 0 0
Saint Martin 1 0 0
Venezuela (Bolivarian Republic of) 1 0 0
European Region
Spain 5,719 0 2
Germany 3,102 0 0
The United Kingdom 3,037 0 0
France 2,673 0 0
Netherlands 1,025 0 0
Portugal 770 0 0
Italy 644 0 0
Belgium 546 0 0
Switzerland 376 0 0
Austria 199 0 0
Israel 174 0 0
Denmark 141 0 0
Sweden 129 0 0
Ireland 101 0 0
Poland 95 0 0
Norway 70 0 0
Hungary 57 0 0
Greece 49 0 0
Slovenia 43 0 0
Luxembourg 41 0 0
Czechia 35 0 0
Romania 32 0 0
Malta 30 0 0
Serbia 23 0 0
Finland 22 0 0
Croatia 17 0 0
Iceland 11 0 0
Slovakia 10 0 0
Estonia 9 0 0
Gibraltar 6 0 0
Lithuania 5 0 0
Andorra 4 0 0
Bulgaria 4 0 0
Bosnia and Herzegovina 3 0 0
Cyprus 3 0 0
Latvia 3 0 0
Monaco 3 0 0
Greenland 2 0 0
Georgia 1 0 0
Montenegro 1 0 0
Republic of Moldova 1 0 0
Russian Federation 1 0 0
Türkiye 1 0 0
African Region
Democratic Republic of the Congo 163 0 0
Nigeria 157 0 4
Ghana 47 0 1
Cameroon 7 0 0
Benin 3 0 0
Central African Republic 3 0 2
Congo 3 0 0
South Africa 3 0 0
Liberia 2 0 0
Western Pacific Region
Australia 70 0 0
Singapore 15 0 0
Japan 4 0 0
New Zealand 4 0 0
China1 3 0 0
Republic of Korea 1 0 0
New Caledonia 1 0 0
Philippines 1 0 0
Eastern Mediterranean Region
United Arab Emirates 16 0 0
Lebanon 6 0 0
Saudi Arabia 6 0 0
Qatar 3 0 0
Morocco 1 0 0
Sudan 1 0 0
South-East Asia Region
India 9 0 1
Thailand 4 0 0
-
Total 35,275 141 12
1 At this time, this figure refers to cases reported in Taipei


2.8 Table - African Region

Summary of Monkeypox cases
As of 15 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
African Region
Democratic Republic of the Congo 163 2 0 0% 0 13 Jun 2022
Nigeria 157 1 0 −100% 0 02 Jan 2022
Ghana 47 2 12 1,100% 0 13 Jun 2022
Cameroon 7 0 0 0% 0 13 Jun 2022
Benin 3 0 0 0% 0 15 Jun 2022
Central African Republic 3 1 0 0% 0 13 Feb 2022
Congo 3 0 0 −100% 0 21 May 2022
South Africa 3 0 0 0% 0 23 Jun 2022
Liberia 2 0 0 −100% 0 01 Aug 2022


2.9 Table - Region of the Americas

Summary of Monkeypox cases
As of 15 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
Region of the Americas
United States of America 10,725 32 3,215 23% 2 03 Jun 2022
Brazil 2,584 12 863 16% 2 10 Jun 2022
Canada 1,059 28 102 −34% 2 03 Jun 2022
Peru 653 20 313 340% 2 28 Jun 2022
Mexico 147 1 56 75% 4 03 Jun 2022
Chile 126 7 58 350% 4 18 Jun 2022
Colombia 84 2 40 43% 2 25 Jun 2022
Argentina 49 1 18 64% 3 03 Jun 2022
Puerto Rico 43 15 22 180% 2 01 Jul 2022
Ecuador 17 1 10 230% 2 14 Jun 2022
Bolivia (Plurinational State of) 11 1 8 170% 2 03 Aug 2022
Dominican Republic 5 0 1 0% 3 06 Jul 2022
Jamaica 4 1 1 0% 3 08 Jul 2022
Costa Rica 3 1 0 0% 6 21 Jul 2022
Guatemala 3 0 1 −50% 4 04 Aug 2022
Panama 2 0 0 −100% 6 06 Jul 2022
Uruguay 2 1 0 −100% 6 31 Jul 2022
Bahamas 1 2 0 0% 6 27 Jun 2022
Barbados 1 4 0 0% 6 19 Jul 2022
Bermuda 1 16 0 0% 6 23 Jul 2022
Guadeloupe 1 2 0 −100% 6 04 Aug 2022
Martinique 1 3 0 0% 6 20 Jul 2022
Saint Martin 1 26 0 −100% 6 04 Aug 2022
Venezuela (Bolivarian Republic of) 1 0 0 0% 6 14 Jun 2022


2.10 Table - Eastern Mediterranean Region

Summary of Monkeypox cases
As of 15 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
Eastern Mediterranean Region
United Arab Emirates 16 2 0 0% 22 24 May 2022
Lebanon 6 1 0 −100% 11 20 Jun 2022
Saudi Arabia 6 0 1 0% 0 14 Jul 2022
Qatar 3 1 1 100% 6 21 Jul 2022
Morocco 1 0 0 0% 62 02 Jun 2022
Sudan 1 0 0 0% 14 01 Aug 2022


2.11 Table - European Region

Summary of Monkeypox cases
As of 15 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
European Region
Spain 5,719 121 777 21% 1 18 May 2022
Germany 3,102 37 215 2% 1 20 May 2022
The United Kingdom 3,037 45 178 −43% 1 07 May 2022
France 2,673 41 250 −47% 1 19 May 2022
Netherlands 1,025 59 66 −18% 1 22 May 2022
Portugal 770 75 60 −22% 1 17 May 2022
Italy 644 11 99 50% 1 19 May 2022
Belgium 546 47 64 −28% 1 19 May 2022
Switzerland 376 43 60 36% 1 21 May 2022
Austria 199 22 38 3% 1 23 May 2022
Israel 174 20 8 −60% 1 21 May 2022
Denmark 141 24 18 −25% 1 23 May 2022
Sweden 129 12 15 −42% 1 18 May 2022
Ireland 101 20 4 −67% 1 16 May 2022
Poland 95 2 19 12% 1 13 Jun 2022
Norway 70 13 5 −58% 1 31 May 2022
Hungary 57 6 9 0% 1 31 May 2022
Greece 49 5 10 43% 1 09 Jun 2022
Slovenia 43 20 5 67% 1 24 May 2022
Luxembourg 41 66 9 120% 1 16 Jun 2022
Czechia 35 3 7 −22% 1 24 May 2022
Romania 32 2 7 75% 1 14 Jun 2022
Malta 30 58 6 −14% 1 30 May 2022
Serbia 23 3 0 −100% 1 17 Jun 2022
Finland 22 4 0 −100% 1 20 May 2022
Croatia 17 4 5 100% 1 24 Jun 2022
Iceland 11 30 0 −100% 1 09 Jun 2022
Slovakia 10 2 2 0% 1 07 Jul 2022
Estonia 9 7 0 −100% 1 28 Jun 2022
Gibraltar 6 178 1 100% 1 02 Jun 2022
Lithuania 5 2 2 −33% 1 04 Aug 2022
Andorra 4 52 0 −100% 1 25 Jul 2022
Bulgaria 4 1 0 0% 1 23 Jun 2022
Bosnia and Herzegovina 3 1 2 100% 1 14 Jul 2022
Cyprus 3 3 0 −100% 1 03 Aug 2022
Latvia 3 2 0 0% 1 03 Jun 2022
Monaco 3 76 3 100% 1 12 Aug 2022
Greenland 2 35 2 100% 1 10 Aug 2022
Georgia 1 0 0 0% 1 15 Jun 2022
Montenegro 1 2 0 0% 1 31 Jul 2022
Republic of Moldova 1 0 1 100% 1 09 Aug 2022
Russian Federation 1 0 0 0% 1 12 Jul 2022
Türkiye 1 0 0 0% 1 30 Jun 2022


2.12 Table - South-East Asia Region

Summary of Monkeypox cases
As of 15 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
South-East Asia Region
India 9 0 0 −100% 9 14 Jul 2022
Thailand 4 0 0 −100% 11 21 Jul 2022


2.13 Table - Western Pacific Region

Summary of Monkeypox cases
As of 15 Aug 2022
Total Cases Total cases per 1M inhabitants Cases in past 7 days 7-day % change in cases Days since last report Date of first reported case
Western Pacific Region
Australia 70 3 12 −8% 4 20 May 2022
Singapore 15 3 0 −100% 10 21 Jun 2022
Japan 4 0 1 0% 5 25 Jul 2022
New Zealand 4 1 1 0% 4 11 Jul 2022
China1 3 0 0 −100% 9 24 Jun 2022
New Caledonia 1 4 0 0% 34 12 Jul 2022
Philippines 1 0 0 0% 17 29 Jul 2022
Republic of Korea 1 0 0 0% 54 22 Jun 2022
1 At this time, this figure refers to cases reported in Taipei


2.14 Table - countries with last case reported 21 or more days ago

Days since last reported case
As of 15 Aug 2022
Last Reported Case Days Elapsed
Eastern Mediterranean Region
Morocco 2 Jun 2022 74
United Arab Emirates 24 Jul 2022 22
African Region
Benin 15 Jun 2022 61
Central African Republic 3 Jul 2022 43
Cameroon 12 Jul 2022 34
South Africa 14 Jul 2022 32
Democratic Republic of the Congo 18 Jul 2022 28
European Region
Georgia 15 Jun 2022 61
Türkiye 30 Jun 2022 46
Russian Federation 12 Jul 2022 34
Latvia 22 Jul 2022 24
Bulgaria 25 Jul 2022 21
Region of the Americas
Venezuela (Bolivarian Republic of) 15 Jun 2022 61
Bahamas 27 Jun 2022 49
Barbados 19 Jul 2022 27
Martinique 20 Jul 2022 26
Bermuda 23 Jul 2022 23
Western Pacific Region
Republic of Korea 22 Jun 2022 54
New Caledonia 12 Jul 2022 34


2.15 Epidemic curve by country

Epidemic curve shown for cases reported up to 15 Aug 2022 to avoid showing incomplete weeks of data. In general, trends should be interpretted with caution, as the majority of countries do not report cases on a daily basis.

 



  1. Weekly reported cases, and weekly cases shown in the epidemic curve are aggregated according to international standard weeks, running from Monday to Sunday.

3 Detailed case data

Detailed case data are acquired via direct reporting of case based data via WHO Member States. Data from cases are reported1 according to the WHO minimum dataset under the International Health Regulations (IHR 2005) Article 6, and subsequently aggreagated and presented below. Note that completeness of records is variable, meaning denominators for each output may be different from one another. All of the following is derived from the detailed case data, and as a result, overall numbers may not be reflective of figures shown with aggregate case numbers. All detailed cases shown are confirmed cases, where the reporting date occured after 01 January 2022.


  1. Note that a small number of detailed case reports are constructed from official public reports about individual cases.

3.1 Reporting coverage

The detailed case dataset was last updated on August 12 2022. As of this date, the total number of detailed confirmed cases reported is 28,105, representing 84.3% of all aggregated cases reported.

The table below indicate the reporting coverage between reported aggregated confirmed cases and detailed confirmed cases by countries and per region.

Note that for all tables below, in order to best align modes of reporting, total confirmed cases are shown as of:

  1. The most recent Friday (12 August) for data in the Region of the Americas.

  2. The most recent Tuesday (09 August) for data in the European Region.

Total cases shown fully as of 15 August are shown in the global trends section.

3.1.1 Table - Coverage by region

Monkeypox reporting completeness
As of 15 Aug 20221
Total Confirmed Cases Total Detailed Confirmed Cases2 % Detailed Cases reported
European Region 17,897 17,509 97.8%
Region of the Americas 14,925 10,371 69.5%
African Region 388 173 44.6%
Western Pacific Region 99 19 19.2%
Eastern Mediterranean Region 33 29 87.9%
South-East Asia Region 13 4 30.8%
1 Total confirmed cases shown as of date of last detailed case report for the WHO Region of the Americas and WHO European Region.
2 Note that in rare cases total detailed cases may exceed total confirmed cases due to ongoing data cleaning issues




3.3 Case profile (overall)

As shown below, and stated previously, the ongoing outbreak is largely developing in men who have sex with men (defined as homosexual or bisexual males in detailed case forms) networks. In the following analyses, we have re-coded men reported as bisexual as men who have sex with men. Note that reported sexual orientation does not necessarily reflect who the case has had recent sexual history with nor does it imply sexual activity. Generally, severity has been low, with few reported hospitalisations and deaths:

Key features of these cases are as follows:

  • 98.7% (18901/19158) of cases with available data are male, the median age is 36 years (IQR: 30 - 43).

  • Males between 18-44 years old continue to be disproportionately affected by this outbreak as they account for 76.9% of cases.

  • Of all cases with available data, 1.3% (257/19158) are female:

    • The majority of of these cases are reported from the European Region (172/257; 67%) and the African Region (61/257; 24%)

    • Of the cases where sexual orientation is reported, the majority are Heterosexual (69/74; 93%).

    • The most commonly reported exposure setting is in a party setting with sexual contact (18/42; 43%), and the most common form of transmission is via sexual encounters (41/75; 55%)

  • Of the 19,591 cases where age was available, there were 103 (0.5%) cases reported aged 0-17, out of which 26 (0.1%) were aged 0-4:

    • The majority of these cases are reported from the African Region (65 /257; 63%).

    • Of the children reported, 0 have reported exposure in a school setting.

  • Among cases with known data on sexual orientation, 97.2% (8382/8627) identified as men who have sex with men. Of those identified as men who have sex with men, 61 / 8382 (0.7%) were identified as bisexual men.

  • Among those with known HIV status 39.0% (3,537/9,059) were HIV-positive. Note that information on HIV status is not available for the majority of cases, and for those for which it is available, it is likely to be skewed towards those reporting positive HIV results.

  • 386 cases were reported to be health workers. However, most were infected in the community and further investigation is ongoing to determine whether the remaining infection was due to occupational exposure.

  • Of all reported types of transmission, a sexual encounter was reported most commonly, with 5,585 of 6,131 (91.1%) of all reported transmission events.

  • Of all settings in which cases were likely exposed, the most common was in party setting with sexual contacts, with 2,131 of 3,254 (65.5%) of all likely exposure categories.

3.3.1 Demographic Information

Note that the proportions shown below should be interpreted with caution. When considering some variables, it is more likely that a yes response will be obtained when compared to a no response after consideration of true proportions of these factors. This is most likely to be true for variables where reported answers can only be yes or no, such as HIV status, health worker status, travel history, hospitalisation, ICU, and death.

Case profiles
As of August 12 2022
Reported values1 Unknown or Missing Value
Yes No
Men who have sex with men 8382 (97.2%) 245 (2.8%) 19458
HIV-Positive 3537 (39.1%) 5519 (60.9%) 19029
Health worker 386 (9.8%) 3537 (90.2%) 24162
Travel History 936 (32.3%) 1962 (67.7%) 25187
Sexual Transmission 5582 (91.1%) 546 (8.9%) 21957
Hospitalised2 952 (7.9%) 11156 (92.1%) 15977
ICU 5 (0.1%) 4673 (99.9%) 23407
Died 2 (0.0%) 12468 (100.0%) 15615
1 Note given true proportions of variables, yes reporting may be common than no reporting
2 May be hospitalised for isolation or medical treatment




3.3.2 Age-sex pyramid



3.3.3 Transmission type

Transmission data were available for 6,131/28,105 (21.8%) of cases.

When considering transmission, note that separating transmission via skin-to-skin contact during sex and transmission via bodily fluids is not possible. While skin-to-skin contact with lesions remains an important transmission route, monkeypox virus has been isolated from semen samples and rectal swabs from confirmed cases.



3.3.4 Exposure settings

Exposure setting data were available for 2,949/28,105 (10.5%) of cases.

Note that multiple exposure settings can be attributed to a single case. Here, differentiation here between party settings and large events is determined by size of the event, although there is no formal size threshold to distinguish the two.



3.4 Case profile (excluding men who have sex with men)

The following outputs apply to cases that are not men who have sex with men, and sexual orientation is known. Other categories of sexual orientation that are reportable are:

  • Heterosexual
  • Lesbian (women who have sex with women)
  • Other

As stated above, men who have sex with men in this case refers to those who have a reported sexual orientation of men whi have sex with men, and men reported as bisexual. As above, note that reported sexual orientation does not necessarily reflect persons who the case has had recent sexual history with nor does it imply sexual activity. Up until this point in time, the 2022 multi-country Monkeypox outbreak has been overwhelmingly concentrated in networks of men who have sex with men For this reason, understanding events in which individuals of other sexual orientation have acquired monkeypox is important to monitor potential of sustained spillover into the general population.

  • 69.0% (165/239) of cases with available data are male; the median age is 34 years (IQR: 28-43).

  • Males between 18-44 years old account for 54.4% of cases.

  • Among those with known HIV status 7.4% (15/203) were HIV-positive. Note that information on HIV status is not available for the majority of cases, and for those for which it is available, it is likely to be skewed towards those reporting positive HIV results.

  • 3 cases were reported to be health workers. However, most were infected in the community and further investigation is ongoing to determine whether the remaining infection was due to occupational exposure.

  • Of all reported types of transmission, sexual encounter was reported most commonly, with 83 of 113 (73.5%) of all reported transmission events.

  • Of all settings in which cases were likely exposed, the most common was in party setting with sexual contacts, with 29 of 67 (43.3%) of all likely exposure categories.

3.4.1 Demographic Information

Note that the proportions shown below should be interpreted with caution. When considering some variables, it is more likely that a yes response will be obtained when compared to a no response after consideration of true proportions of these factors. This is most likely to be true for variables where reported answers can only be yes or no, such as HIV status, health worker status, travel history, hospitalisation, ICU, and death.

Case profiles (excluding men who have sex with men)
As of August 12 2022
Reported values1 Unknown or Missing Value
Yes No
Men who have sex with men 0 245 (100.0%) 0
HIV-Positive 15 (7.4%) 188 (92.6%) 42
Health worker 3 (1.7%) 171 (98.3%) 71
Travel History 35 (34.3%) 67 (65.7%) 143
Sexual Transmission 83 (73.5%) 30 (26.5%) 132
Hospitalised2 41 (17.7%) 190 (82.3%) 14
ICU 0 124 (100.0%) 121
Died 0 235 (100.0%) 10
1 Note given true proportions of variables, yes reporting may be common than no reporting
2 May be hospitalised for isolation or medical treatment




3.4.2 Age-sex pyramid



3.4.3 Transmission type

Transmission data were available for 113/245 (46.1%) of cases.

When considering transmission, note that separating transmission via skin-to-skin contact during sex and transmission via bodily fluids is not possible. While skin-to-skin contact with lesions remains an important transmission route, monkeypox virus has been isolated from semen samples and rectal swabs from confirmed cases.



3.4.4 Exposure settings

Exposure setting data were available for 63/245 (25.7%) of cases that were not men who have sex with men.

Note that multiple exposure settings can be attributed to a single case. Here, differentiation here between party settings and large events is determined by size of the event, although there is no formal size threshold to distinguish the two.



3.5 Symptomatology

Although most cases in current outbreaks have presented with mild disease symptoms, monkeypox virus (MPXV) may cause severe disease in certain population groups (young children, pregnant women, immunosuppressed persons)

Among the cases who reported at least one symptom, the most common symptom is fever and is reported in 72% of cases with at least one reported symptom. Note that identifying true denominators for symptomatology is difficult due to a general lack of negative reporting and symptom definitions that may vary between countries’ reporting systems.

A bar chart and table showing symptoms is shown below. Here any rash refers to one or more rash symptoms (systemic, oral, genital, or unknown location), and any lymphadenopathy refers to either general or local lymphadenopathy.

3.5.1 Bar chart - Symptoms

3.5.2 Table - Symptoms

Summary of symptoms
As of August 12 2022
Number
Fever 14987 (72.4%)
Any rash 14184 (68.5%)
Systemic rash 11600 (56.0%)
Genital rash 5279 (25.5%)
Any lymphadenopathy 4201 (20.3%)
Lymphadenopathy 4038 (19.5%)
Local lymphadenopathy 3417 (16.5%)
Fatigue 3105 (15.0%)
Headache 2977 (14.4%)
Muscle ache 2898 (14.0%)
Oral rash 1270 (6.1%)
Chills 366 (1.8%)
Vomiting 113 (0.5%)
Asymptomatic 10 (0.0%)
Conjunctivitis 0
Cough 0
Sore throat 0
Other 0

 


4 In focus: West and Central Africa

Since 1970, human cases of monkeypox have been reported in 9 countries in the WHO African region: Cameroon, Central African Republic, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Gabon, Liberia, Nigeria, and Sierra Leone. The true burden of monkeypox in these countries is not known. This section specifically focuses on those countries in the African region with a history of monkeypox, in order to highlight any differences in epidemiology between those countries and those within the ongoing 2022 monkeypox outbreak without a history of monkeypox. Notably, while the ongoing 2022 monkeypox outbreak has been associated with Clade II of monkeypox virus, historically outbreaks have been driven by that and Clade I.

Historically, the sexual component of transmission in the countries above has been thought to contribute less to human to human transmission of monkeypox than has been observed in the ongoing global outbreak. It should also be noted that there is limited testing capacity for monkeypox in many of these countries, which has led to underascertainment of monkeypox cases.

In 2022, as of 15 Aug 2022, there have been 335 confirmed cases of monkeypox reported in these countries and 6 deaths. These represent 1% and 50% of global cases and deaths respectively. In addition, 173 (52% of all cases) detailed cases have been reported to WHO.

Of those cases with detailed data:

  • 110 male cases (64.3%) and 61 female cases (35.7%) have been reported

  • The median age is 25 (IQR: 11 - 35).

  • Of the 168 cases where age was available, there were 65 (38.7% of total) cases reported aged 0-17, out of which 21 (12.5% of total) were aged 0-4.

  • There are currently no detailed cases for which transmission or exposure setting detail is available

Trends from these countries are shown below:

4.1 Epidemic curve by date of notification (cases)

Epidemic curve shown for cases reported up to 15 Aug 2022 to avoid showing incomplete weeks of data.

4.2 Epidemic curve by date of notification (deaths)

Epidemic curve shown for deaths reported up to 15 Aug 2022 to avoid showing incomplete weeks of data.

4.3 Epidemic curve by date of onset

This epidemic curve is shown for those cases with detailed case data, giving date of onset.

4.4 Age-sex pyramid

 


5 Disclaimers

5.1 Data Overview and Visualizations

The WHO 2022 monkeypox global trends report aims to provide frequently updated data visualizations. Caution must be taken when interpreting all data presented, and differences between information products published by WHO, national public health authorities, and other sources using different inclusion criteria and different data cut-off times are to be expected. While steps are taken to ensure accuracy and reliability, all data are subject to continuous verification and change. All counts are subject to variations in case detection, definitions, laboratory testing, and reporting strategies between countries, states and territories.

WHO makes no warranties or representations regarding the contents, appearance, completeness, technical specifications, or accuracy of the report. WHO disclaims all responsibility relating to, and shall not be liable for, any use of the report, the results of such use, or the reliance thereon.

WHO reserves the right to make updates and changes to the report without notice, and accepts no liability for any errors or omissions in this regard.

The user of the report is responsible for the interpretation and use of the analysis and outputs performed by the report. The submission of content to the report does not imply WHO’s approval or endorsement of that content, or that the content is appropriate for any purpose or meets any established standard or requirement

Any designations employed or presentation by the user in its use of the app, including tables and maps, do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers and boundaries.

All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).

A dispute exists between the Governments of Argentina and the United Kingdom of Great Britain and Northern Ireland concerning sovereignty over the Falkland Islands (Malvinas).

6 Acknowledgements

We gratefully acknowledge the input of national public health staff involved in surveillance activities and data submission to WHO, the European Centre for Disease Prevention and Control (ECDC) for the provision of surveillance data collected via the TESSy platform, as well as external partners who contributed additional insights and contextual information on the data.